1039P First-in-human phase I study of givastomig, a novel Claudin 18.2/4-1BB bispecific antibody in advanced solid tumors.
Saved in:
| Title: | 1039P First-in-human phase I study of givastomig, a novel Claudin 18.2/4-1BB bispecific antibody in advanced solid tumors. |
|---|---|
| Authors: | Ku, G.1 (AUTHOR), Shen, L.2 (AUTHOR), Klempner, S.J.3 (AUTHOR), Pan, H.4 (AUTHOR), Kratz, J.5 (AUTHOR), Liang, X.6 (AUTHOR), Deng, Y.7 (AUTHOR), Kim, S.8 (AUTHOR), Wang, Z.9 (AUTHOR), Feller, L.10 (AUTHOR), Powderly, J.11 (AUTHOR), Dayyani, F.12 (AUTHOR), Schneider, R.E.13 (AUTHOR), Girda, E.14 (AUTHOR), Berlin, J.D.15 (AUTHOR), Spencer, K.16 (AUTHOR), Nguyen, M.T.17 (AUTHOR), Wang, V.17 (AUTHOR), Xu, C.17 (AUTHOR), Zhu, A.18 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS631-S631. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2023.09.2178 |
